28/02/2026
A big part of my visit to the factory was looking at what is currently being developed in immunology.
Three areas stood out! A sublingual treatment aimed at reducing recurrent urinary tract infections in higher risk patients.
An immune-based approach for children with recurrent respiratory infections and wheezy episodes, including those who go on to develop asthma.
And further advances in sublingual immunotherapy. Allergoid vaccines have now been combined with additional immune-modulating components to enhance protection while aiming to reduce side effects.
Not all of this sits purely within allergy, but they are definitely things I will keeping an eye on for my patients!